Sigma Investment Counselors Inc. Buys 867 Shares of Intuitive Surgical, Inc. $ISRG

Key Points

• Sigma Investment Counselors Inc. increased its stake in Intuitive Surgical, Inc. by 5.3%, holding a total of 17,233 shares worth approximately $9.36 million after purchasing an additional 867 shares during the 2nd quarter.
• Intuitive Surgical reported earnings of $2.19 per share, exceeding analysts' expectations of $1.93, along with a quarterly revenue of $2.44 billion, which is a 21.4% increase year-over-year.
• Investment analysts have set a consensus price target of $580.29 for Intuitive Surgical, with 14 analysts rating it as a Buy and one as a Sell.

Sigma Investment Counselors Inc. lifted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 5.3% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 17,233 shares of the medical equipment provider's stock after purchasing an additional 867 shares during the period. Sigma Investment Counselors Inc.'s holdings in Intuitive Surgical were worth $9,364,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also made changes to their positions in the stock. Dumont & Blake Investment Advisors LLC bought a new position in shares of Intuitive Surgical in the 2nd quarter worth $215,000. International Assets Investment Management LLC boosted its position in shares of Intuitive Surgical by 11.0% in the 2nd quarter. International Assets Investment Management LLC now owns 2,640 shares of the medical equipment provider's stock worth $1,435,000 after purchasing an additional 261 shares during the last quarter. VIRGINIA RETIREMENT SYSTEMS ET Al bought a new position in shares of Intuitive Surgical in the 2nd quarter worth $13,371,000. Signature Estate & Investment Advisors LLC boosted its position in shares of Intuitive Surgical by 85.0% in the 2nd quarter. Signature Estate & Investment Advisors LLC now owns 1,426 shares of the medical equipment provider's stock worth $775,000 after purchasing an additional 655 shares during the last quarter. Finally, Quotient Wealth Partners LLC boosted its position in shares of Intuitive Surgical by 9.0% in the 2nd quarter. Quotient Wealth Partners LLC now owns 1,791 shares of the medical equipment provider's stock worth $973,000 after purchasing an additional 148 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Stock Up 2.6%

Shares of NASDAQ ISRG opened at $446.13 on Friday. The business's 50 day moving average price is $454.97 and its two-hundred day moving average price is $495.75. The company has a market cap of $159.93 billion, a PE ratio of 62.22, a price-to-earnings-growth ratio of 4.69 and a beta of 1.61. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, topping analysts' consensus estimates of $1.93 by $0.26. The firm had revenue of $2.44 billion for the quarter, compared to the consensus estimate of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The business's revenue was up 21.4% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.78 earnings per share. As a group, research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Analysts Set New Price Targets

Several research analysts have weighed in on the company. Royal Bank Of Canada reiterated an "outperform" rating and set a $615.00 target price on shares of Intuitive Surgical in a report on Tuesday, August 19th. Weiss Ratings reiterated a "hold (c+)" rating on shares of Intuitive Surgical in a report on Wednesday, October 8th. Truist Financial reduced their target price on Intuitive Surgical from $600.00 to $525.00 and set a "buy" rating on the stock in a report on Wednesday. Evercore ISI reduced their target price on Intuitive Surgical from $535.00 to $450.00 and set an "in-line" rating on the stock in a report on Tuesday, October 7th. Finally, UBS Group set a $529.00 price target on Intuitive Surgical in a research note on Monday, October 13th. Fourteen investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $580.29.

Insider Transactions at Intuitive Surgical

In other news, EVP Myriam Curet sold 4,500 shares of the business's stock in a transaction that occurred on Friday, July 25th. The stock was sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the completion of the sale, the executive vice president owned 353 shares in the company, valued at $173,845.44. The trade was a 92.73% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Amy L. Ladd sold 335 shares of the business's stock in a transaction that occurred on Thursday, September 4th. The stock was sold at an average price of $440.69, for a total value of $147,631.15. Following the sale, the director owned 739 shares of the company's stock, valued at approximately $325,669.91. This represents a 31.19% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 45,224 shares of company stock worth $21,716,492 over the last quarter. Company insiders own 0.70% of the company's stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.